![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, October 08, 2023 4:57:00 PM
None of the material I have read, justifying the use of new drugs with no possibility of knowing what the long term effects of the drugs may be, considers that the disease, itself, could be new, as we see with the novel coronavirus, which has claimed over 1.2M American lives.
With a novel and lethal virus, developing and using novel therapeutics is the only chance there is of saving lives.
Here's an interesting insight from the New Jersey health department written in March of 2020 in this regard.
"The World Health Organization (WHO) has decided to name the disease caused by the novel coronavirus "COVID-19" and refers to the virus that causes it as the "COVID-19 virus." CO for corona, VI for virus, D for disease, and 19 for the year the outbreak was first recognized, late in 2019."
https://covid19.nj.gov/faqs/coronavirus-information/about-the-virus/what-is-the-official-name-of-the-novel-coronavirus#:~:text=The%20World%20Health%20Organization%20(WHO,first%20recognized%2C%20late%20in%202019.
However, there was already an existing law, the 21st Century Cures Act, which detailed the provisions for MCM (Medical Countermeasures) cures.
https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/21st-century-cures-act-mcm-related-cures-provisions
There was a MCM priority review voucher associated with this law, but it expired last week. But I mention this law as an avenue for us, in the event it may prove useful. I hope that we just get our EUA this week, and don't need an alternative way of getting it.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM